Mylan CEO Heather Bresch Disastrously Defends EpiPen Price Hike and Her Own $16M Pay Raise

Mylan Pharmaceuticals CEO Heather Bresch appeared on CNBC Thursday morning in an effort to mitigate the controversy sparked by the company's decision to exponentially increase the price of the life-saving EpiPen drug.

When asked if she understands the bipartisan outrage brought on by the company's pricing path, Heather Bresch appeared to take zero responsibility.

"The American Medical Association has said this is basically the same product it was in 2009 and yet the price has gone up three or four hundred fold," CNBC's Brian Sullivan told Bresch.

"Look, no one's more frustrated than me," the CEO said in response.

Bresch tried to thwart criticism of the steep price hike by discussing the marketing and distribution costs of EpiPens and her efforts to make the drug more widely available.

“We’re manufacturing the product, distributing the product, enhancing the product, investing,” she said. “When we took over this product eight years ago, there was very, very little awareness. We have doubled the lives of patients who are carrying an EpiPen. We have passed legislation in 48 states to allow undesignated EpiPens to be in schools,” Bresch told CNBC. 

The CEO went on to warn of a healthcare crisis similar to the 2007 mortgage crisis.

"I am hoping this is an inflection point for this country. Our healthcare is in a crisis. It's no different than the mortgage financial crisis back in 2007. This bubble is going to burst," Bresch said.

When asked why her own compensation rose from $2.5 million in 2007 to $18.9 million in 2015, Bresch dodged that question as well.


Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal
{{ }}